Age 0 3 0 3 B-age
> 4 5 4 5 O
or 6 8 6 8 O
= 9 10 9 10 O
to 11 13 11 13 O
50 14 16 14 16 B-lower_bound
years 17 22 17 22 I-lower_bound
of 23 25 23 25 O
age 26 29 26 29 B-age

Breast 0 6 30 36 B-treatment
implant 7 14 37 44 I-treatment
in 15 17 45 47 O
the 18 21 48 51 O
involved 22 30 52 60 O
breast 31 37 61 67 O

Clearly 0 7 68 75 O
demarcated 8 18 76 86 O
tumor 19 24 87 92 B-cancer
on 25 27 93 95 O
magnetic 28 36 96 104 B-treatment
resonance 37 46 105 114 I-treatment
imaging 47 54 115 122 I-treatment
( 55 56 123 124 I-treatment
MRI 56 59 124 127 I-treatment
) 59 60 127 128 I-treatment
, 60 61 128 129 O
as 62 64 130 132 O
determined 65 75 133 143 O
by 76 78 144 146 O
treating 79 87 147 155 O
physician 88 97 156 165 O
( 98 99 166 167 O
MRI 99 102 167 170 O
may 103 106 171 174 O
be 107 109 175 177 O
done 110 114 178 182 O
after 115 120 183 188 O
enrollment 121 131 189 199 O
if 132 134 200 202 O
not 135 138 203 206 O
done 139 143 207 211 O
prior 144 149 212 217 O
) 149 150 217 218 O

Female 0 6 219 225 B-gender
sex 7 10 226 229 O

HER2- 0 5 230 235 B-clinical_variable
using 6 11 236 241 O
the 12 15 242 245 O
current 16 23 246 253 O
College 24 31 254 261 O
of 32 34 262 264 O
American 35 43 265 273 O
Pathologists 44 56 274 286 O
guidelines 57 67 287 297 O

Invasive 0 8 298 306 B-cancer
ductal 9 15 307 313 I-cancer
carcinoma 16 25 314 323 I-cancer

Medical 0 7 324 331 O
conditions 8 18 332 342 O
that 19 23 343 347 O
may 24 27 348 351 O
increase 28 36 352 360 O
risk 37 41 361 365 O
for 42 45 366 369 O
poor 46 50 370 374 O
cosmetic 51 59 375 383 O
outcome 60 67 384 391 O
( 68 69 392 393 O
i.e. 69 73 393 397 O
Lupus 74 79 398 403 B-chronic_disease
, 79 80 403 404 O
rheumatoid 81 91 405 415 B-chronic_disease
arthritis 92 101 416 425 I-chronic_disease
, 101 102 425 426 O
scleroderma 103 114 427 438 B-chronic_disease

Patients 0 8 439 447 O
who 9 12 448 451 O
have 13 17 452 456 O
received 18 26 457 465 O
or 27 29 466 468 O
will 30 34 469 473 O
be 35 37 474 476 O
receiving 38 47 477 486 O
neoadjuvant 48 59 487 498 B-treatment
systemic 60 68 499 507 I-treatment
therapy 69 76 508 515 I-treatment
, 76 77 515 516 O
endocrine 78 87 517 526 B-treatment
therapy 88 95 527 534 I-treatment
, 95 96 534 535 O
or 97 99 536 538 O
targeted 100 108 539 547 O
agents 109 115 548 554 O

Planning 0 8 555 563 O
breast 9 15 564 570 O
conserving 16 26 571 581 O
surgery 27 34 582 589 O
including 35 44 590 599 O
sentinel 45 53 600 608 B-treatment
node 54 58 609 613 I-treatment
biopsy 59 65 614 620 I-treatment

Planning 0 8 621 629 O
mastectomy 9 19 630 640 B-treatment

Subjects 0 8 641 649 O
without 9 16 650 657 O
placement 17 26 658 667 O
of 27 29 668 670 O
a 30 31 671 672 O
biopsy 32 38 673 679 O
clip 39 43 680 684 O
at 44 46 685 687 O
the 47 50 688 691 O
diagnostic 51 61 692 702 O
procedure 62 71 703 712 O
who 72 75 713 716 O
are 76 79 717 720 O
unwilling 80 89 721 730 O
to 90 92 731 733 O
undergo 93 100 734 741 O
clip 101 105 742 746 B-treatment
placement 106 115 747 756 I-treatment

Unable 0 6 757 763 O
to 7 9 764 766 O
meet 10 14 767 771 O
dosimetric 15 25 772 782 O
constraints 26 37 783 794 O
due 38 41 795 798 O
to 42 44 799 801 O
tumor 45 50 802 807 B-cancer
location 51 59 808 816 O
and/or 60 66 817 823 O
patient 67 74 824 831 O
anatomy 75 82 832 839 O

â‰¥10 0 3 840 843 O
% 3 4 843 844 I-lower_bound
expression 5 15 845 855 O
of 16 18 856 858 O
ER 19 21 859 861 B-clinical_variable
and/or 22 28 862 868 O
PR 29 31 869 871 B-clinical_variable

